A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors
Lee, Jih-Hsiang, Chen, Tom Wei-Wu, Hsu, Chih-Hung, Yen, Yu-Hsin, Yang, James Chih-Hsin, Cheng, Ann-Lii, Sasaki, Shun-ichi, Chiu, LiYin, Sugihara, Masahiro, Ishizuka, Tomoko, Oguma, Toshihiro, Tajima,Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-019-00745-z
Date:
March, 2019
File:
PDF, 1.27 MB
english, 2019